- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
The Evolving Annual Wellness Visit
The annual wellness visit is beneficial for patients, providers, and payers with an emphasis on preventive care for early intervention.
Today, we're diving deep into a crucial aspect of preventive healthcare: the annual wellness visit. Our guest is Christopher Wheelock, MD, a clinical transformation physician executive at Highmark Health, responsible for developing payer and provider collaborations to move toward value-based care. In the past, he was heavily involved with developing the workflow, patient scripting and templating for the annual wellness visit when CMS first established it in 2011 as part of the Affordable Care Act.
In today’s episode, Wheelock sheds light on the various elements of the annual wellness visit, including self-assessments of psychosocial issues and screenings for conditions like dementia and incontinence. He also explains the expansion of services in 2025 for Medicare beneficiaries.
We also explore the intricacies of coding and billing for these visits, especially if they go beyond the scope of the annual wellness visit; the value they bring to patients, providers, and payers; and the critical role of effective communication and preparation to maximize the benefit of the annual wellness visit.
Listen above or on one of these podcast services:
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
How Access to SMA Treatment Varies Globally and by Insurance Type
March 18th 2025Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic advances in treating spinal muscular atrophy (SMA) are not uniformly making it into the hands of patients who could benefit.
Read More
